Technical Data
C1035-30E
CAPN10, NT (Calpain-10, Calcium-activated Neutral Proteinase 10, CANP 10, KIAA1845)
Description:
CAPN10 is ubiquitous, well-conserved family of calcium-dependent, cysteine proteases. This protein is heterodimers consisting of an invariant small subunit and variable large subunits. The large catalytic subunit has four domains: domain I, the N-terminal regulatory domain that is processed upon calpain activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, the calmodulin-like calcium-binding domain. It is an atypical calpain in that it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. The protein is similar in organization to calpains 5 and 6.

Applications:
Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:50-1:100
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGPurified
SizeStorageShippingSourceHost
100ug-20°CBlue IceHumanRabbit
Concentration:
~0.25mg/ml
Immunogen:
Synthetic peptide selected from the N-terminal region of human CAPN10 (KLH).
Purity:
Purified by ammonium sulfate precipitation.
Form
Supplied as a liquid in PBS, 0.09% sodium azide.
Specificity:
Recognizes human CAPN10.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1.Unsal,T., Konac,E. J. Assist. Reprod. Genet. 26(4), 205-216 (2009). 2.Garcia-Escalante,M.G. Invest Clin 50(1), 65-76 (2009). 3.Yilmaz,M., Yurtcu,E. J. Endocrinol. Invest. 32(1), 13-17 (2009). 4.Evans,J.C., Frayling,T.M. Am. J. Hum. Genet. 69(3), 544-552 (2001).